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Abstract
Non-alcoholic fatty liver disease (NAFLD) is a common disease with a spectrum of presentations. The current study utilized a
lithogenic diet model of NAFLD. The diet was fed to mice that are either resistant (AKR) or susceptible (BALB/c and C57BL/6)
to hepatitis followed by molecular and flow cytometric analysis. Following this, a similar approach was taken in congenic
mice with specific mutations in immunological genes. The initial study identified a significant and profound increase in
multiple ligands for the chemokine receptor CCR2 and an increase in CD44 expression in susceptible C57BL/6 (B6) but not
resistant AKR mice. Ccr22/2 mice were completely protected from hepatitis and Cd442/2 mice were partially protected.
Despite protection from inflammation, both strains displayed similar histological steatosis scores and significant increases in
serum liver enzymes. CD45+CD44+ cells bound to hyaluronic acid (HA) in diet fed B6 mice but not Cd442/2 or Ccr22/2 mice.
Ccr22/2 mice displayed a diminished HA binding phenotype most notably in monocytes, and CD8+ T-cells. In conclusion,
this study demonstrates that absence of CCR2 completely and CD44 partially reduces hepatic leukocyte recruitment. These
data also provide evidence that there are multiple redundant CCR2 ligands produced during hepatic lipid accumulation and
describes the induction of a strong HA binding phenotype in response to LD feeding in some subsets of leukocytes from
susceptible strains.
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Introduction
Non-alcoholic fatty liver disease (NAFLD) is an increasingly
common disease of humans affecting approximately 30–40% of
individuals in the United States depending on the study population
[1,2]. NAFLD represents a spectrum of hepatic diseases from
benign lipid accumulation in the liver to more severe non-
alcoholic steatohepatitis (NASH) which may lead to hepatocellular
carcinoma and liver failure [3]. Although a variety of factors
including high caloric intake, limited physical activity and other
co-morbidities such as diabetes are known to predispose individ-
uals to NAFLD the factors which promote progression of NAFLD
to NASH are less clear [4].
The roles of chemokine ligands and their associated receptors
are well established in the recruitment of immune cells during
inflammation. Ovariectomized mice fed high fat diets display
worse hepatitis than their intact counterparts and this exacerbation
of disease is associated with increased liver expression of CCL2
[5]. Human patients with NASH also display hepatic upregulation
of many chemokines and other leukocyte adhesion molecules [6].
Others have noted systemic elevations of some cytokines and
chemokines in patients with NASH [7]. Consistent with the
findings in human patients, CCR2 inhibition in obese prone mice
fed a ‘‘Western’’ diet reduced adipose tissue inflammation and
associated comorbidities including hepatic macrophage recruit-
ment [8,9].
Previously, we used a lithogenic diet model of NAFLD/NASH
to demonstrate that the cell cycle gene Atm was critical in
responding to lipid-mediated oxidative damage in affected livers.
Further, we showed that in mice lacking Atm, lithogenic diet
induced hepatocyte apoptosis and fibrosis were significantly
diminished [10]. The goal of the present study was to exploit
the lithogenic diet model to identify hepatic inflammation
susceptible and resistant mouse strains and to establish immuno-
logical determinants of disease in the liver. We found that C57BL/
6 mice are susceptible BALB/c mice are intermediate and AKR
mice are resistant to hepatitis. Protection in AKR mice
corresponded to a significant reduction in hepatic chemokine
production and a decrease in recruitment of CD44+CD45+ cells.
We observed that deletion of CCR2 on B6 background mice
completely eliminates hepatic inflammation, stellate cell activation
and hepatic fibrosis despite hepatic lipid accumulation and
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significant elevations in serological markers of hepatocellular
damage. Further, we found that progression of disease is impeded
in mice lacking the leukocyte adhesion molecule CD44 and we
describe an interaction between CD44 and hepatic hyaluronic
acid (HA) in this process. Finally, we show that in the absence of
CCR2, CD44 mediated HA binding is not induced on CD8+ T-
cells and monocytes. Collectively, our studies show that CD44 and
CCR2 contribute to hepatitis in a model of NAFLD despite




Male 4–5 week-old mice were purchased (BALB/cJ, AKRJ,
C57BL/6J) from The Jackson Laboratory (Bar Harbor, ME) or
bred in house (Cd442/2, Ccr22/2). CCR2 reporter mice were
kindly donated by Eric Pamer (Memorial Sloan Kettering) and
then bred in house [11]. Mice were housed in an AAALAC
accredited facility under barrier conditions, free of known viral
and bacterial pathogens. Animals were given irradiated feed and
sterile water. Beginning at 8–10 weeks of age mice were either fed
a standard rodent diet (SD) (Harlan Teklad 7912) or a completely
synthetic lithogenic diet (LD) (1.0% cholesterol, 0.5% cholic acid,
15.8% total lipid Harlan Teklad TD.09237) for 1–4 weeks. At the
conclusion of the study mice were euthanized and animals were
either bled by cardiac puncture or perfused with sterile PBS and
tissues were collected for analysis. For gross morphologic analysis
mice were weighed, euthanized by CO2 and livers were extracted
intact and weighed.
Ethics Statement
All animal work was done in accordance with PHS guidelines
and was approved by Cornell’s institutional animal care and use
committee (Protocol # 2009–0010).
Liver Leukocyte Preparation
Initial studies in B6, AKR and BALB/c mice utilized all of the
liver except three 30 mg tissue sections which were used for
histopathology and RNA preparation. Subsequent studies in B6
Ccr22/2 and Cd442/2 mice utilized the entire liver. Perfused livers
were macerated and strained through a sterile stainless steel mesh
and tissue residue was diluted in PBS and centrifuged (10 minutes,
1250 rpm). The tissue was then digested with collagenase as
described [12] washed with PBS and made into a single cell
suspension. Finally, Percoll gradient centrifugation (40%/80%)
was performed to further purify the leukocyte fraction.
Liver Histopathology
Livers were either formalin fixed and processed for standard
histopathological analysis or they were flash frozen in optimum
cutting temperature (O.C.T.) embedding media (Sakura Finetek,
Torrance, CA) for subsequent fluorescence immunohistochemis-
try. Flash frozen tissues were fixed and permeabilized in acetone,
blocked with serum appropriate to the antibody (Jackson
Immunoresearch, West Grove, PA) and then labeled with
antibodies to targets (ABCAM, Cambridge, MA) followed by
secondary fluorochrome conjugated antibodies (Jackson Immu-
noresearch, West Grove, PA). Standard histological slides were
formalin fixed and processed for hematoxylin and eosin (H&E) or
pico-sirius red staining and examined by light microscopy [10].
Oil-red-O staining was conducted on formalin fixed or frozen
sections and slides were examined by light microscopy. Immuno-
fluorescently stained tissue was analyzed by confocal microscopy
(Leica SP5). H&E and pico-sirius red stained tissues were
examined by a veterinary pathologist with expertise in animal
models of liver disease who was blinded to group identity. Slides
were scored for inflammation, steatosis and fibrosis on an
ascending 0–4 scale using previously established criteria (0 = none,
1 =mild, 2 =moderate, 3 = severe, 4 = very severe) [10].
Cell Staining and Flow Cytometry
Leukocyte enriched fractions from Percoll gradient centrifuga-
tion were blocked in flow staining buffer (1% BSA, 0.05% NaN3 in
PBS) with 10% normal mouse serum (Jackson Immunoresearch,
West Grove, PA). Cells were then incubated with fluorochrome-
conjugated antibodies specific for CD45, CD44, CD11b, CD11c,
CD3, CD8, CD4, Ly6G (GR-1), Ly6C, F480, NK1.1, CD49b,
B220, and CD19 (Becton Dickson, Franklin Lakes, NJ and
eBioscience, San Diego, CA) in flow staining buffer for 30 minutes
on ice, washed by centrifugation and fixed in 3% buffered
paraformaldehyde. For the Hyaluronic acid (HA) binding assay,
cells were incubated with HA-FITC (Santa Cruz Biotechnology,
Santa Cruz, CA) for 30 minutes on ice, washed and fixed as above
[13]. Total liver preps were gated on FSC/SSC to exclude debris
and cell clumps. Cells were gated based upon single staining of
CD45+ cells and the FSC/SSC gate of the CD45+ cells was
applied to all samples (Fig. S1). Approximately 20,000–100,000
cells per analyses were acquired on a FACSCalibur (for the initial
strain comparison analysis) or FACSCantoII (for all subsequent
studies; Becton Dickson, Franklin Lakes, NJ). Acquired data were
analyzed with FlowJo software (Treestar, Ashland, OR). Cell
numbers were calculated based upon total cell counts after
purification and positive staining for the markers described.
Quantitative PCR
Hepatic RNA was prepared using commercially available tissue
RNA isolation kits (Omega bio-tek, Norcross, GA 30071) from the
livers of SD fed B6 and AKR mice (n = 3 each) and LD fed B6,
AKR and Ccr22/2 mice (n= 3 each). RNA was converted to
cDNA and inflammatory genes were analyzed by semi-quantita-
tive PCR using the commercially available ‘‘Inflammatory
Cytokines & Receptors PCR Array’’ (Qiagen Valencia, CA).
Gene expression levels were normalized to the internal house-
keeping genes (5 housekeeping genes) included on the individual
plates and fold changes were acquired by comparing to SD fed
AKR or B6 controls using the DD Ct method [10]. LD or SD fed
B6 mice were statistically compared to AKR or Ccr22/2 mice
utilizing company supplied software [14].
Serum Enzyme Analysis
Immediately after euthanasia, blood was collected and placed
into microtainers coated with lithium heparin (Becton Dickson,
Franklin Lakes, NJ). Tubes were centrifuged and serum was
collected. Alanine aminotransferase (ALT), sorbitol dehydrogenase
(SDH) and glutamate dehydrogenase (GLDH) where evaluated
from individual, non-diluted, fresh samples by a commercial
veterinary reference lab (Animal Health Diagnostic Center,
Cornell University, Ithaca, NY).
Statistical Analyses
Data were analyzed by ANOVA or t-test for parametric data,
by the Mann-Whitney-test for nonparametric data and by Fisher’s
exact test for correlative data using commercially available
software (Prism, Graphpad, La Jolla, CA).
CCR2 and CD44 Promote Hepatic Inflammation
PLOS ONE | www.plosone.org 2 June 2013 | Volume 8 | Issue 6 | e65247
Results
C57BL/6 Mice are Susceptible, BALB/c Mice are
Intermediate and AKR Mice are Resistant to Lithogenic
Diet Feeding Induced Hepatitis
After four weeks of lithogenic diet (LD) feeding C57BL/6 (B6)
mice developed hepatitis demonstrated by an approximate 10 fold
increase in CD45+ inflammatory cells present in the liver when
compared to standard diet (SD) fed controls (Fig. 1A, *P,0.05).
BALB/c mice fed the same diet also had significant increases in
CD45+ cells compared to their SD fed counterparts; however, the
CD45+ cell counts were significantly less than B6 mice fed the
same diet. AKR mice did not develop significant increases in
CD45+ cells compared to their SD fed counterparts and they had
significantly fewer liver leukocytes than B6 mice fed the diet
(Fig. 1A). Cell number differences between susceptible and
resistant mice were confirmed by histological examination
(Fig. 1B–F). B6 mice developed moderate to severe multifocal to
coalescing hepatitis composed predominantly of mononuclear cells
(Fig. 1E arrows). In contrast, BALB/c mice developed only minor
focal areas of hepatitis with a more noticeable polymorphonuclear
component (Fig. 1D arrows). Inflammatory infiltrates rarely
occurred in AKR mice (Fig. 1C, F). Despite striking differences
in inflammatory cell infiltration, oil-red-o stained sections of the
liver confirmed that susceptible B6, intermediate BALB/c and
resistant AKR mouse livers all accumulated excess lipid (Fig. 1 G–
I). Consistent with previous publications SD fed mice contained
negligible hepatic lipid (Fig. 1 J–L) [10,15]. Flow cytometric
analysis revealed that B6 mice developed increases in all
inflammatory cell types examined (Fig. 2).
We next examined hepatic leukocyte preparations for CD44
expression because this molecule is upregulated in NASH patients
and is important in leukocyte recruitment to hepatic sinusoids
[6,16]. We found that CD44 expression on Percoll enriched
leukocyte preparations was markedly increased in susceptible B6
mice (Fig. 3A) and moderately increased in BALB/c mice (Fig. 3B)
after 4 weeks of LD feeding. In contrast, resistant AKR mice did
not display increased expression of CD44 after LD feeding
(Fig. 3C).
Susceptible B6 Mice Develop a Striking Proinflammatory
Cytokine Signature after Lithogenic Feeding
To determine if there were specific immune function genes that
were associated with hepatitis susceptibility, a pathway focused
quantitative PCR based array was performed on livers from
susceptible (B6) and resistant (AKR) mice. LD fed B6 mice
significantly upregulated (P,0.05, 3 fold or greater change) 41 out
of 84 inflammatory cytokines, chemokines and ligands included in
the array (Fig. 4; Group 1 are genes exhibiting significant changes
in LD fed B6 mice and Group 2 are genes exhibiting significant
changes in both SD fed B6 and LD fed B6 mice compared to SD
fed AKR mice). Of note, LD fed B6 mice upregulated numerous
chemokines associated with the recruitment of CCR2 positive cells
(CCL2, CCL7, CCL8 and CCL12; Fig. 4; Group 1). In the case of
CCL12, this ligand was upregulated significantly (P,0.05, 3 fold
or greater change) in B6 SD fed mice compared to SD fed AKR
mice (Fig. 4; Group 2) indicating that even in the basal state this
chemokine is more highly expressed in B6 mice. In addition, LD
fed B6 mice upregulated several potent pro-inflammatory cyto-
kines including IFNc, IL-1b, and TNF-a. In contrast, in LD fed
AKR mice there were no significant changes in inflammatory
genes compared to SD controls (Fig. 4, Fig. S2). In some instances,
in LD fed AKR mice the mean fold change (Fig. 4B) appeared
quite large (e.g. CCL6) but the results were highly variable (Fig. 4A)
and failed to achieve statistical significance compared to SD fed
AKR controls. There were also a large number of cytokines which
were not significantly altered in any groups of mice fed the LD
compared to SD fed AKR controls (Fig. S2).
CCR2 and CD44 Knockout Mice are Protected from
Hepatitis Despite Histological Evidence of Steatosis and
Elevated Hepatic Serum Enzymes
Because CCR2 and its ligands are upregulated in B6 mice and
because CD44 expression is increased in LD fed B6 mice we
wanted to determine if these two molecules were critical for
hepatitis formation in this model. Therefore, we analyzed whether
CCR2 and CD44 gene deleted mice were resistant to LD induced
hepatitis. In contrast to B6 animals, Ccr22/2 mice displayed a
striking absence of inflammatory infiltration either early (1 week)
or later (4 weeks) during LD feeding (Fig. 5A). Cd442/2 mice
displayed significant hepatitis at 1 and 4 weeks when compared to
SD fed controls. However, inflammatory infiltration at 4 weeks
was significantly less than B6 mice at the same time-point (Fig.5A).
In contrast, hepatitis rapidly developed in B6 mice and
significantly increased between 1 and 4 weeks of LD feeding
(Fig. 5A). We asked whether the defect in recruitment was
associated with any particular cell type. After 4 weeks of LD
feeding, CD442/2 mice recruited significantly fewer monocytes
and Gr-1+ (Ly6G+) monocytes compared to B6 mice (Fig. 6 H–I).
LD fed Ccr22/2 failed to appreciably recruit any of the cell types
examined (Fig. 6). Histopathological assessment of livers at 4 weeks
of diet feeding confirmed the differences noted by flow cytometry
(Fig. 5. B, C, D). Specifically, while B6 mice developed a similar
pattern of moderate to severe multifocal inflammation to that
shown in Fig. 1B inflammatory foci were absent in Ccr22/2 mice
(Fig. 5B, 5D). In Cd442/2 mice, scattered inflammatory foci were
noted most prevalently around the large vessels of the liver
(Fig. 5C, black arrows) and histopathological scoring confirmed
mild to moderate inflammation consistent with flow-cytometry
data (Fig. 5D).
Gross examination of the mice after 4 weeks of feeding
demonstrated that LD consumption did not promote obesity as
indicated by similar weights compared to SD fed control animals
(Fig. 5E). However, all mice fed LD displayed significant increases
in liver weights compared to SD fed B6 mice consistent with
hepatomegaly due to hepatic lipid accumulation (Fig. 5E). Livers
of B6 (Fig. 5I), Ccr22/2 (Fig. 5G, I) and Cd442/2 mice (Fig. 5H, I)
each developed significant and equivalent histological evidence of
moderate steatosis as demonstrated by oil-red-O staining and
histopathological scoring. Further, all LD fed groups, regardless of
hepatitis protection or resistance, displayed significant serological
elevations in hepatic enzymes indicative of hepatocellular damage
(Fig. 5 J–L). Taken together, these data indicate that Ccr22/2 are
completely protected and Cd442/2 mice are partially protected
from hepatic inflammation despite similar histological evidence of
steatosis and serological evidence of hepatocellular damage when
compared to B6 mice.
CD11b+ CCR2+ Cells Recruited to the Liver Display an
Inflammatory Monocyte Phenotype
To further characterize the CCR2+ population of recruited
monocytes we performed staining for Gr-1 (Ly6G) and iNOS,
molecules associated with inflammatory monocytes, in the livers of
CCR2 reporter mice fed the LD for four weeks. The majority of
CCR2+, CD11b+ monocytes recruited to the liver were Gr-1+
(Fig. 7 A and C). Additionally, these cells expressed iNOS (Fig. 7 B
and D). These findings are consistent with the marked increases in
CCR2 and CD44 Promote Hepatic Inflammation
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Gr-1+ monocytes noted in B6 but not Ccr22/2 mice (Fig. 6 I). The
monocytes recruited during LD feeding possess the hallmarks of
inflammatory monocytes.
CD44 Mediates Hyaluronic Acid Binding During LD
Feeding
One of the mechanisms underlying recruitment of CD44+ cells
to the liver involves CD44 binding to hyaluronic acid (HA)
Figure 1. C57BL/6 mice are highly susceptible to diet induced hepatitis. (A) Liver leukocytes (CD45+ cells) were quantified in C57BL/6 (B6),
BALB/c, and AKR mice fed either a standard diet (SD) or 4 weeks of lithogenic diet (LD) (*P,0.05 compared to SD controls, **P,0.05 compared to all
groups; n = 3–5 per group). (B and E) H&E staining of liver from LD fed B6 mice under low and high power magnification respectively. Arrows in B
point to inflammatory foci and E shows a representative inflammatory focus. (C and F) H&E staining of liver from LD fed AKR mice under low and high
power magnification respectively. Oil-red-O staining showing lipid accumulation in BALB/c (G), B6 (H) and AKR mice (I) fed the LD but not in those fed
the SD (J–L). Bars in B and C=100mm; bars in D–L= 20mm.
doi:10.1371/journal.pone.0065247.g001
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expressed on hepatic sinusoids [16]. However, not all forms of
CD44 bind to HA [17]. Since Cd442/2 mice displayed diminished
inflammatory infiltrates we wanted to determine if HA binding on
hepatic leukocytes increased during LD feeding. Liver leukocytes
of SD mice, regardless of genotype, did not bind appreciably to
HA (Fig. 8A). LD feeding induced a population of HA binding
liver leukocytes in B6 mice (Fig. 8B). In contrast, hepatic
leukocytes of both Ccr22/2 and Cd442/2 mice remain HA
binding negative after 4 weeks of LD feeding (Fig. 8B). Significant
increases in HA binding were not present at 1 week of LD feeding
but were seen at 4 weeks (Fig. 8C). HA binding did not occur
appreciably on CD442 cells and only occurred on a subset of
CD44+ cells consistent with the fact that not all CD44 binds HA
(Fig. 8D).
Figure 2. LD fed hepatitis susceptible B6 mice display uniform increases in hepatic leukocyte populations. (A–H) Composition of liver
leukocytes in B6, BALB/c, and AKR mice fed SD or LD (*P,0.05 compared to SD controls). Leukocyte populations are defined as follows: NK cells,
CD49b+ CD32; NK-T cells, CD3+ CD49b+; B-cells, CD19+ B220+; dendritic cells, CD11c+, macrophages, CD11b+ Ly6C2, neutrophils, CD11b+ Ly6C+.
doi:10.1371/journal.pone.0065247.g002
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Frozen sections of livers were next examined to determine if
CD45+ cells co-localized in areas which were positive for HA. In
B6 mice fed SD (Fig. 9A) or Ccr22/2 mice (Fig. 9B) few CD45+
cells were found, consistent with flow-cytometric and histological
data. LD fed B6 mice displayed numerous CD45+ cells which were
CD44+ and often associated with HA+ regions of the liver (Fig. 9C,
9E). In contrast, in Cd442/2 mice, CD45+ CD442 areas were
present but co localization with HA was reduced when compared
to LD fed B6 mice (Fig. 9D, 9E). Taken together these data
indicate that in LD fed B6 mice, CD45+CD44+ cells bind to HA
and localize to HA positive areas.
HA Binding Occurs Primarily on Monocytes, CD8+ T-cells
and Dendritic Cells
The lack of HA binding by hepatic leukocytes from Ccr22/2
mice during LD feeding was an unexpected finding so we next
examined if this was the result of altered CD44 expression or a
difference in the binding capacity of the CD44 molecules. In
response to LD feeding wild-type mice displayed increased
numbers of CD44 intermediate (int) and high (hi) expressing
CD4+, CD8+, monocytes, and dendritic cells (Fig. 10A and B;
shaded region=LD fed B6 mice, solid line =LD fed Ccr22/2
mice, dashed line =SD fed B6 mice). In contrast LD fed Ccr22/2
mice displayed significantly fewer CD44int/hi expressing CD4+,
CD8+ and monocytes and a lack of any CD44hi CD8+ T-cells
(Fig. 10A and B; solid black line). When compared to SD fed mice,
LD fed Ccr22/2 mice demonstrated significantly increased
numbers of CD44int/hi CD4+ and dendritic cells (Fig. 10A and
B; solid black line). The surface expression of CD44 on other cell-
types examined was not altered by diet or strain (Fig. S3A).
Next we examined the ability of CD44int/hi cells to bind to HA.
When CD45+CD44int/hi expressing cells were exclusively exam-
ined B6 mice displayed greater HA binding when compared to
Ccr22/2 mice (Fig. 10 C and D; B6: shaded region, Ccr22/2: solid
line). When specific CD44int/hi cell-types were examined signifi-
cantly increased HA binding was noted on CD8+ cells and
monocytes from B6 mice compared to Ccr22/2 mice (Fig. 10 E
and F; B6: shaded region, Ccr22/2: solid line). With regard to
CD4+ cells, HA binding was relatively low in both B6 and Ccr22/2
mice but nevertheless there was a significant difference between
these 2 groups (Fig. 10 E and F; B6: shaded region, Ccr22/2: solid
line). Binding of HA on dendritic cells did not differ between the
groups but was elevated when compared to other cell types
examined (Fig. 10 E and F; B6: shaded region, Ccr22/2: solid line,
Fig. S3B). Other cell types displayed low and highly variable levels
of HA binding (Fig. S3B). These data demonstrate that CD44
expression in response to LD feeding occurs primarily on T-cells,
monocytes and dendritic cells. This induction is diminished in
Ccr22/2 mice on all but dendritic cells. HA binding occurs
primarily on CD8+ T-cells, monocytes and dendritic cells and
Ccr22/2 mice fail to induce HA binding in both monocytes and
CD8 T-cells.
CCR2 Deficiency Prevents Hepatic Proinflammatory
Cytokine Production
To determine if elimination of cellular infiltrates in Ccr22/2
mice results in an altered local cytokine/chemokine profile we
performed focused pathway arrays on Ccr22/2 mice. Overall,
Ccr22/2 mouse livers failed to display the proinflammatory
signature of their wild-type counterparts which we previously
reported (Fig. 11A individual mice, Fig. 11B mean values). There
were three distinct groups of changes which occurred. A subset of
genes was significantly changed in only LD fed B6 mice compared
to SD fed B6 mice (Group 1) while a second subset was
significantly upregulated in both LD fed groups with LD fed B6
mice still exhibiting significantly elevated expression levels
compared to LD fed Ccr22/2 mice (Group 2). A third group of
genes was upregulated and statistically indistinguishable between
LD fed B6 and Ccr22/2 mice. Finally, there was a subset of genes
which was not significantly altered in any of the experimental
groups (Fig. S4). Overall, B6 mice fed the LD developed significant
(P,0.05, +/23 fold or greater change) alterations in 49 of 84
genes examined (Groups 1, 2 and 3) when compared to SD fed B6
controls (Fig. 11). In contrast, Ccr22/2 mice significantly altered
only 17 of 84 analyzed genes and only 8 total genes were expressed
at statistically equivalent levels to B6 LD fed mice (Fig. 11, Group
3). Overall, Ccr22/2 mice were protected from the production of
deleterious pro-inflammatory cytokines in the liver. Interestingly,
Tnf-a is markedly upregulated (.50 fold) in LD fed B6 mice. This
cytokine is a critical inducer of CD44 upregulation and HA
binding in both monocytes and T-cells consistent with the altered
HA binding exhibited in these cell types in LD fed B6 but not
Ccr22/2 mice [18,19].
CCR2 and CD44 Promote Stellate Cell Activation and
Fibrosis During Hepatic Lipid Accumulation
Since inflammatory mediators are capable of promoting fibrosis
we wanted to determine if Cd442/2 and Ccr22/2 mice are
protected from this pathology during LD feeding. We evaluated
expression of smooth muscle actin, a marker of stellate cell
activation, and we performed pico-sirius red staining to evaluate
Figure 3. Hepatitis susceptible mouse strains display increased
liver leukocyte CD44 expression in response to LD feeding.
Hepatic leukocyte preparations were gated on forward and side-scatter
and CD44 levels of B6 (A), BALB/c (B) and AKR (C) mice were examined
by flow cytometry. Solid lines represent mice on LD and shaded lines
represent mice on SD.
doi:10.1371/journal.pone.0065247.g003
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for the presence of fibrosis. B6 mice displayed significantly more
activated stellate cells compared to all other groups of mice as
evidenced by increased normalized smooth muscle actin expres-
sion (Fig. 12 A, B). In contrast, Ccr22/2 mice fed LD displayed
levels of smooth muscle actin staining which were nearly identical
to SD fed mice and were not noticeably evident by immunoflu-
orescence (Fig. 12 A, C). Cd442/2 mice had a moderate, yet
statistically insignificant, elevation in smooth muscle acting
staining when compared to SD fed B6 mice; however, levels were
statistically increased over Ccr22/2 mice fed the LD (Fig. 12 A, D).
Consistent with smooth muscle actin staining, SD fed B6 mice
developed no fibrosis on pico-sirius red staining (Fig. 12 E, I) and
livers from LD fed B6 mice had significant increases in fibrosis
compared to all other groups (Fig. 12 F, J, I). Ccr22/2 mice did not
display areas of positive fibrosis staining (Fig. 12 G, K, I) and
Cd442/2 mice developed sporadic areas of mild fibrosis primarily
in perivascular regions in association with inflammatory infiltrates
(Fig. 12 H, L). Fibrosis scores for Cd442/2 mice were significantly
elevated when compared to Ccr22/2 and SD fed B6 mice
(Fig. 12I). Taken together, these data indicate that LD fed Ccr22/2
mice are completely protected from fibrosis and Cd442/2 mice are
partially protected.
Discussion
Our data reveal the independent and overlapping roles of
CCR2 and CD44 in development and progression of hepatic
inflammation during fatty liver disease. Our findings reinforce
studies in humans that have identified CCR2 and CD44 as being
increased in NASH patients and they establish a possible link
between these two molecules in lipid mediated hepatitis progres-
sion in so far as Ccr22/2 mice are largely protected from CD44
mediated HA binding [6,7,20]. The monocytes emerging in the
liver during hepatitis progression bare the hallmarks of inflam-
matory monocytes as they display a CCR2+, Gr-1+ (Ly6G), iNOS+
phenotype. Further, livers from susceptible LD fed B6 mice when
compared to SD fed B6 mice display pronounced increases in
Figure 4. Livers of LD fed B6 mice display a proinflammatory cytokine profile. (A) Expression levels of the indicated genes in livers from
individual mice relative to SD fed AKR mice (n = 3 per group). (B) Averaged values for each strain relative to AKR mice fed SD. Group 1 genes are
significantly upregulated in B6 LD only; Group 2 genes are significantly upregulated in both B6 LD and B6 SD groups. A significant change is defined
as $3 fold difference with P,0.05 relative to SD AKR controls.
doi:10.1371/journal.pone.0065247.g004
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expression of IFNc, TNF-a, CXCL9, CXCL10, and CCL20
which are each associated with inflammatory monocyte activation.
Finally, susceptible B6 mice display a proinflammatory signature
consistent with the recruitment of a broad range of inflammatory
cells.
Figure 5. Ccr22/2 and Cd442/2 mice are resistant to hepatitis during LD feeding despite lipid accumulation and elevated serum
enzymes. (A) Infiltration of CD45+ inflammatory cells into the livers of B6, Ccr22/2, and Cd442/2 at one and four weeks of LD or SD feeding (*P,0.05
compared to SD controls, **P,0.05 compared to all groups, n = 3–6 per group). (B and C) Respective low power images from Ccr22/2 and Cd442/2
mice fed the LD for four weeks. In C, arrows point to inflammatory infiltrates restricted to large liver vessels. (D) Histological scoring of mice confirms
moderate to severe inflammation in B6 LD mice and mild to moderate inflammation in Cd442/2 mice (**P,0.05 compared to all groups, *P,0.05
compared to SD fed or Ccr22/2 LD fed mice; scores represent means of n = 6–12 mice per group). (E) Lithogenic diet feeding did not induce obesity
in any genotype. (F) Lithogenic diet feeding induced significant hepatomegaly in all strains (*P,0.05 compared to all other mice, n = 4–6 per group).
(G–H) Oil-red-o staining of livers from Ccr22/2(G), and Cd442/2 (H) mice demonstrate an accumulation of excess lipid irrespective of genotype. (I)
Steatosis scoring demonstrates a significant increase in steatosis in all genotypes in response to LD feeding for 4 weeks compared to SD fed mice
(**P,0.05 compared to all groups n = 6–10 mice per group). (J–L) Serum levels of hepatic enzymes are elevated in LD fed mice irrespective of
genotype. (J and K, *P,0.05 against all LD groups; L, *P,0.05 compared to LD fed B6 and Ccr22/2 mice; n = 4–5 per group). B and C, bar represents
100mm; G–H, bar represents 20mm.
doi:10.1371/journal.pone.0065247.g005
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CCR2 is known to be a key molecule for the recruitment of T-
cells, monocytes and dendritic cells so it is not surprising that these
cells were reduced in Ccr22/2 mice [21–23]. Interestingly, Ccr22/
2 mice demonstrate broad protection against the induction of
chemokines responsible for the recruitment of other inflammatory
cells. Specifically, B6, but not Ccr22/2 mice display marked
increases in chemokine ligands, other than Ccl2, which are known
to recruit monocytes, T-cells and dendritic cells (Ccl1, Ccl3, Ccl4,
Ccl7, Ccl8), B-cells (Ccl20), neutrophils (Ccl3/Mip1a, and Pf4/
Cxcl4), and NK and NK T-cells (Ccl3, Ccl4, Ccl8) [22,24–26]. In
this way, CCR2 deficiency seems to offer pleiotropic protection
from LD mediated hepatic inflammatory cell recruitment.
Previous work by others demonstrated that deficiency of CCL2,
a chemokine ligand of CCR2, did not prevent hepatitis in a
methionine-choline deficient (MCD) mouse model of NASH [27].
More recently, a study demonstrated that inhibition of CCL2 with
an L-enantiomeric RNA oligonucleotide prevented monocyte
accumulation in mice fed a MCD chronically and those treated
with carbon tetrachloride acutely [28]. Our findings demonstrate
that several independent CCR2 ligands (CCL2, CCL7, CCL8 and
CCL12) are upregulated during hepatic lipid accumulation. These
multiple redundant pathways may, in part, explain the previous
discrepancies in these publications. That is, if pharmacological
inhibition also affected other similar CCR2 ligands this could
explain why gene disruption of CCL2 did not prevent disease but
pharmacological inhibition did.
CD44 has previously been shown to be elevated in human
NASH patients [6,20]. We found that CD442/2 mice were
incompletely, yet significantly protected from inflammation during
LD feeding. Further, we found elevations in CD44 expression on
monocytes, T-cells, and dendritic cells in LD fed B6 mice. CD8+
T-cells displayed a mixed intermediate and high CD44 expressing
phenotype. Others have described similar CD8+ CD44 interme-
diate subsets generated under sterile inflammatory conditions and
have characterized them as an early memory T-cell which
develops into a CD44hi phenotype [29]. Although not critically
examined here it seems probable that the mixed T-cell population
in this study is similar to those previously described [29]. We
demonstrated that HA binding of leukocytes was absent early
during LD feeding (1 week) but significantly increased by 4 weeks
in susceptible B6 mice. Furthermore, we observed co-localization
between CD45+ cells and HA in liver tissue sections in susceptible
mice. Co-localization data should be interpreted with caution
because HA is a known component of the fibrotic response and we
saw increased fibrosis in B6 LD mice particularly in areas around
inflammatory infiltrates. Indeed even in CD442/2 mice there was
a moderate amount of co-localization noted. Likewise, detection of
HA by confocal microscopy was limited and only large aggregates
of HA were readily detectable.
Figure 6. Ccr22/2 and Cd442/2 mice display altered inflammatory cell recruitment during LD feeding. (A–I) Composition of Liver
Leukocytes in mice fed SD or LD (*P,0.05 compared to SD controls; **P,0.05 compared to all other groups). Cells are identified as in figure legend 2.
doi:10.1371/journal.pone.0065247.g006
CCR2 and CD44 Promote Hepatic Inflammation
PLOS ONE | www.plosone.org 9 June 2013 | Volume 8 | Issue 6 | e65247
In Cd442/2 mice there was an increase in liver CD45+ cells
after one week of LD feeding, but then CD45+ numbers stabilized.
In contrast, B6 mice displayed both an early increase and a
continued influx of CD45+ cells. Taken together, these data
demonstrate that HA binding to CD44 may represent an
important step in progression of inflammation associated with
LD induced liver disease. There are several reasons why this
interaction may promote inflammation. First, as previously
mentioned, HA serves as a critical ligand for immune cell
recruitment [18,19,30]. Additionally, irrespective of immune
recruitment, HA binding to CD44 induces a pronounced
proinflammatory response which will further promote the
recruitment of leukocytes [31].
Interestingly, Ccr22/2 mice also displayed decreased HA
binding which appeared to occur primarily because of a lack of
induction of the HA binding isoform of CD44. On inspection of
hepatic expression data this finding is consistent with the known
biological regulation of CD44 and HA binding. Specifically, we
noted a marked (.50 fold) increase in Tnf-a expression in LD fed
B6 mice which was absent in Ccr22/2 mice. TNF-a stimulates
CD44 expression on T-cells and monocytes and TNF-a is the
primary cytokine responsible for the production of the HA binding
variant of CD44 on both T-cells and monocytes [18,19,32]. Ifn-c
which is also upregulated in B6 but not Ccr22/2 mice has also
been shown to enhance TNF-a mediated binding of CD44 to HA
[33]. It therefore seems reasonable to hypothesize that increased
HA binding in B6 but not Ccr22/2 mice is the result of the
markedly increased Tnf-a and Ifn-c expression in B6 mice.
Interestingly, HA binding will then feed forward on this cycle by
inducing greater active CD44 expression and greater cytokine and
chemokine production including the production of more CCL2
[31]. Dendritic cells of Ccr22/2 mice fed the LD bound to HA;
however, the overall number of dendritic cells in these mice is still
markedly reduced consistent with the known role of CCR2 in their
recruitment [23,34]. The exact mechanism of induction of HA
binding in dendritic cells of Ccr22/2 mice is unknown but Ccr22/2
Figure 7. Monocytes in the liver of LD fed mice display an inflammatory phenotype. Co-expression of CCR2 and Gr-1 (A), as well as CCR2
and iNOS (B) in livers of CCR2 reporter mice. Flow cytometric analysis of hepatic CCR2+, CD11b+, Ly6C2 cells (solid line) confirms increase expression
of Gr-1 (C) and iNOS (D) on CCR2+, CD11b+ cells compared to gray shaded regions which represent CCR2+, CD11b22 populations stained for the
same markers.
doi:10.1371/journal.pone.0065247.g007
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mice did develop mild yet statistically significant increases in both
Il-3 and Il-1B which are two cytokines known to promote HA
binding [18,30]. Alternatively, HA binding is a phenotypic
occurrence during dendritic cell maturation so this phenotype
may indicate that dendritic cells in the livers of LD fed mice, are
displaying a maturation phenotype [35]. There is strong evidence
that TLR stimulation of resident leukocytes occurs during steatosis
and Tlr4 is known to induce dendritic cell maturation so it follows
that this may be involved in this phenotypic conversion [36,37].
Recent evidence also suggests that lipid rich dendritic cells
represent a distinct pro-inflammatory cell population in the livers
of mice and humans [38]. It is therefore intriguing to speculate
that dietary lipid loading of hepatic dendritic cells may also play a
role in induction of this HA binding phenotype.
In addition to resistance to hepatitis, Ccr22/2 mice were also
completely protected from stellate cell activation and development
of hepatic fibrosis. These findings are consistent with acute carbon
tetrachloride mouse models which demonstrate that CCR2+, Gr-
1+, iNOS+monocytes are important for the induction of fibrosis
[39]. Increased expression of the fibrotic markers TGFb, CCL7
and PF4 and the abundant expression of Th1 cytokines in B6 mice
compared to Ccr22/2 is also consistent with the fibrosis protected
phenotype [39]. In contrast, Cd442/2 mice displayed an
intermediate phenotype with regard to stellate cell activation
and fibrosis. Stellate cell activation and fibrosis appeared
dependent upon the presence of inflammatory cell infiltrates,
because in areas of the liver lacking inflammatory foci, there was
little fibrosis noted even in susceptible strains. Others have
demonstrated that osteopontin, a ligand of CD44, is important
for promoting fibrosis and promotion of NAFLD/NASH [40,41].
The osteopontin gene Spp1 was present in our pathway array but
was not significantly altered by LD at 4 weeks of feeding in either
susceptible or resistant strains. In an MCD model of NAFLD
others have demonstrated that increased hepatic osteopontin
expression was not detected until 4 weeks of MCD diet feeding
[42]. Once this induction occurred it remained high throughout
the study. Therefore, the lack of induction of the osteopontin gene
in our study may merely indicate that gene expression was
analyzed prior to the onset of detectable osteopontin production.
We therefore, cannot rule out the possibility that osteopontin also
played a role in the protection of Cd442/2 mice in this model.
Indeed based upon other models and data in humans the role of
Figure 8. Hepatic leukocytes from B6 mice bind to hyaluronic acid in a CD44 dependent manner. (A) HA binding of CD45+ cells from a
representative SD fed B6, Ccr22/2 and Cd442/2mouse. (B) HA binding of CD45+ cells from a representative four week LD fed B6, Ccr22/2 and Cd442/
2mouse. (C) Cumulative HA binding results over time (n = 3–6 per group). (D) In CD45+ leukocytes from LD fed B6 mice, HA binding occurs on a
subpopulation of CD44+ cells.
doi:10.1371/journal.pone.0065247.g008
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osteopontin in disease progression is convincing [40–42]. Our data
do however describe an alternative and perhaps complementary
proinflammatory mechanism of CD44 mediated hepatic inflam-
mation through activation of hyaluronic acid binding.
Our data are consistent with a recent study using a choline
deficient mouse model of NAFLD/NASH which demonstrated a
critical role for CCR2 in disease pathogenesis [15]. In that study,
Ccr22/2 mice displayed significant decreases in steatosis and liver
recruitment of inflammatory monocytes. The authors also
demonstrated that TLR4 and TLR9 signaling in Kupffer cells
initiated Ccl2 production [15]. Our results support and extend
their study in a different model of hepatic lipid accumulation
because we show that failure to recruit monocytes leads to a defect
in recruitment of a variety of cell-types and a widespread reduction
of a proinflammatory cytokine and chemokine production
consistent with the role of CCR2 in the recruitment of other
inflammatory cells [14,21,43]. We also demonstrated an inhibition
of CD44-HA binding predominantly in monocytes and CD8+ T-
cells of Ccr22/2 mice thereby linking CD44 recruitment and
CCR2. In the choline deficient model, Ccr22/2 mice were
significantly protected from inflammation, lipid accumulation and
serum elevations in ALT [15]. Our data are also consistent with a
recent publication which demonstrated that Cd442/2 mice fed a
high-fat diet were protected from hepatic inflammation and
inflammatory cytokines [44]. In that study, Cd442/2 mice were
also protected from hepatic steatosis, displayed significantly
smaller livers when compared to wild-type counterparts, and
had significantly reduced serum liver enzyme values [44]. With
regard to the steatosis protection demonstrated in these two studies
but not in the current study, these differences are probably the
result of the method of disease induction. Specifically, LD feeding
delivers lipid to the hepatobiliary system largely through chylomi-
cron remnants and occurs shortly after ingestion [45–47]. Obesity
and deposition of lipid in visceral adipose tissue does not occur,
likewise insulin resistance does not develop [48,49]. Once in the
liver, fatty acids from chylomicron remnant absorption may
directly contribute to pathogenesis and cholesterol will induce
triglyceride and fatty acid production through LXR responsive
genes [50–52] Our data demonstrating steatosis without inflam-
mation in Ccr22/2 and Cd442/2 mice are likely the result of the
lipid source being directly related to dietary absorption thereby
negating the role of the immune system on hepatic lipid
Figure 9. Leukocytes co-localize with HA in B6 diet fed mice. (A) B6 mice fed SD and (B) Ccr22/2 mice fed LD display rare CD45+ inflammatory
cells (white arrows). (C) After 4 weeks of LD feeding B6 mice develop marked foci of CD45+ CD44+ cells that are often co-localized with HA expressing
regions of the liver. (D) In contrast, Cd442/2 mice develop CD45+ inflammation without CD44 expression and decreased co-localization with HA. (E)
Quantitative assessment of co-localization of HA with inflammatory foci demonstrates a high degree of co-localization in B6 mice and a moderate
amount in Cd442/2 mice. CD45+ inflammatory foci were counted and scored positive if clusters of CD45+ cells occurred in direct contact with HA
positive staining. Inflammatory foci were not identified in Ccr22/2 and SD fed mice and as a result they were not quantified. (*P,0.05, data represent
counts analyzed by contingency tables and Fisher’s exact test from n= 4 mice per group).
doi:10.1371/journal.pone.0065247.g009
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accumulation. We did not specifically examine hepatic lipids
biochemically and cannot rule out the possibility that there are
biochemical differences in hepatic lipid content, but our data do
demonstrate that Ccr22/2 and Cd442/2 mediated protection may
occur independently of histological protection from steatosis.
Serological elevation of hepatic enzymes despite protection from
inflammation was also a surprising finding in Ccr22/2 and Cd442/
2 mice. However, these data are consistent with several studies
analyzing human populations with NAFLD/NASH. That is,
serum ALT poorly correlates with histological grade of inflam-
mation and fibrosis [53–55]. Even when the same patients are
followed over time, serial ALT level analysis fails to predict
histological changes in NAFLD patients [54]. We have previously
demonstrated in this model that lipid accumulation in hepatocytes
leads to a marked increase in reactive oxygen species and oxidative
DNA mediated damage [10]. It is well established that, oxidative
stress of hepatocytes ultimately leads to cytosolic and mitochon-
drial membrane damage which may result in cell death by necrosis
or apoptosis [56]. Based upon significant increases in histological
steatosis score, and lipid induced hepatomegaly it seems likely that
Figure 10. CCR2 deletion reduces HA binding and CD44 expression in T-cells and monocytes. (A) Binding of HA by liver leukocytes of LD
fed B6 and Ccr22/2 mice. (A) Proportion of hepatic CD44int/hi cells in SD and LD fed B6 and Ccr22/2 mice. LD fed B6 mice show significant increases in
CD44int/hi CD8+ cells, CD4+ cells, monocytes and dendritic cells when compared to SD fed control mice and significant increases in CD8+ cells, CD4+
cells, and monocytes when compared to LD fed Ccr22/2 mice (*:P,0.05 compared to SD fed group, **:P,0.05 compared to all groups). (B):
Histograms showing CD44 expression in CD4+ cells, CD8+ cells, monocytes and dendritic cells from LD fed B6 mice (gray shaded region), LD fed
Ccr22/2mice (solid line) or SD fed B6 mice (dashed line) demonstrating an increase in CD44 expression in LD fed B6 mice compared to LD fed Ccr22/2
mice in all cells with the exception of dendritic cells. Bars represent gates for CD44int/hi cells. (C) Binding of HA by CD44 int/hi liver leukocytes of LD fed
B6 and Ccr22/2 mice demonstrating increased HA binding in CD44int/hi populations (*:P,0.05). (D) Representative histogram showing HA binding by
CD44 int/hi liver leukocytes from B6 (shaded) and Ccr22/2 (solid-line) mice. Bar represents gate used for positive and negative staining. (E) Percentage
of HA binding of various CD44int/hi leukocyte populations demonstrating significant increases in the binding of CD4+ cells, CD8+ cells and monocytes
in B6 LD mice compared to Ccr22/2 LD mice. Both groups exhibited a high degree of HA positive binding in dendritic cells (*:P,0.05). Representative
histograms showing HA binding by various populations of CD44 int/hi liver leukocytes from B6 (shaded) and Ccr22/2 (solid-line) mice. Bar represents
gate used for positive and negative staining for each cell type. For individual cell-types gating was determined by the background HA staining of a
non-target group of CD442/low expressing cells.
doi:10.1371/journal.pone.0065247.g010
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elevations in these enzymes are occurring at least in part as a result
of lipid accumulation and oxidative mediated hepatocyte damage.
We hypothesize, based upon our data and others, that in
lithogenic diet feeding, hepatic lipid accumulation leads to
hepatocellular damage by lipid mediated oxidant products
[10,56]. Ccl2 expression is then induced, in part through TLR
stimulation of resident inflammatory cells [15,37]. This in turn
recruits CCR2 positive cells, primarily monocytes. These recruited
Figure 11. Livers of LD fed Ccr22/2 mice fail to develop the proinflammatory cytokine response of LD fed B6 mice. (A) Gene transcript
levels in livers of individual LD fed B6 and Ccr22/2 mice relative to B6 SD. (B) Mean values of individual mice relative to B6 SD controls. Group 1 genes
significantly altered in B6 LD only; Group 2 genes significantly altered in both B6 LD and Ccr22/2 LD groups and B6 LD mice are significantly increased
over Ccr22/2 LD mice; Group 3 genes significantly altered in B6 LD and Ccr22/2 LD groups. A significant change is defined as $3 fold difference with
P,0.05 relative to SD B6 controls (n = 3 per group; LD fed Ccr22/2 mice were compared to the previously described cohort, Fig. 4, of SD and LD fed
B6 mice).
doi:10.1371/journal.pone.0065247.g011
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cells produce additional proinflammatory cytokines and chemo-
kines, thereby inducing the recruitment of other inflammatory cell-
types. T-cells and macrophages increase CD44 expression and
become HA binding in response to marked upregulation of TNFa.
This binding promotes hepatic retention and induces additional
proinflammatory cytokine and chemokine production. Cytokine
production then contributes to stellate cell activation and hepatic
fibrosis. Our data are an important step forward in understanding
the contribution and interaction of the CCR2 and CD44 pathways
in hepatic inflammation associated with hepatic lipid accumula-
tion. Our study support and extend recent findings demonstrating
the role of CCR2 and CD44 in inflammation during hepatic
steatosis. This study demonstrates that pro-inflammatory cytokine
production in the liver is mediated at least in part by CCR2+ cells
because genetic deletion of CCR2 alleviates both cellular and
molecular inflammation even in livers that are lipidotic. Further-
more, we show that CD44-HA binding occurs over the course of
disease progression and that CCR2 deficiency partially eliminates
this phenotype.
Supporting Information
Figure S1 Gating strategy and representative staining
data from a B6 mouse fed the LD for 4 weeks. Total liver
preps were gated on FSC/SSC to exclude debris and cell clumps.
Cells were gated based upon single staining of CD45+ cells and the
FSC/SSC gate of the CD45+ cells was applied to all samples.
Representative plot of C56BL/6 CD45+ cells after 4 weeks of LD
showing CD11b/Ly6C staining.
(TIF)
Figure S2 Transcript levels of a subset of genes remain
unaltered. (A) Expression levels of the indicated genes in livers
from individual mice relative to SD fed AKR mice (n = 3 per
group). (B) Averaged values for each strain relative to AKR mice
fed a SD. Genes displayed did not achieve statistical significance. *
Xcr was significantly elevated in SD fed B6 mice compared to SD
fed AKR mice but data were unreliable because the gene was
undetectable in SD AKR controls and weakly expressed in all
groups.
(TIF)
Figure 12. Livers from LD fed B6 mice display activated stellate cells and fibrotic lesions. (A) Liver tissue sections were stained with a-
smooth muscle actin antibody (aSMA) and cell nuclei were stained with DAPI. a-smooth muscle actin signal (green fluorescence) was normalized to
cell number (blue fluorescence) (n = 4 mice per group, 5 tissue sections per mouse; *P,0.05 compared to Ccr22/2 mice; **P,0.05 compared to all
groups). A representative section from LD fed B6 mice (B), Ccr22/2 mice (C) and Cd442/2 mice (D). (E–H) Low and (J–L) high power magnification of
pico-sirius stained SD fed B6 mice (E), LD fed B6 mice (F,J), Ccr22/2 mice (G,K) and Cd442/2 mice (H,L). (I) Fibrosis score was determined by sirius-red
positive staining (**P,0.05 compared to all groups, *P,0.05 compared to B6 SD and Ccr22/2 LD). In E–H and J–L the bar corresponds to 25mm.
doi:10.1371/journal.pone.0065247.g012
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Figure S3 CD44 surface expression and HA binding are
not significantly different in some cell-types. (A) CD44 int/
hi expressing B, NK, NK T-cells, and neutrophils remain
unchanged regardless of diet or genotype. (B) HA binding
phenotype of B-cells, NK cells, NK T-cells and neutrophils does
not vary in LD fed Ccr22/2 and LD fed B6 mice. Neutrophils
exhibit a minor HA binding phenotype and all other cells fail to
bind to HA in response to LD feeding.
(TIF)
Figure S4 Transcript levels of a subset of genes remain
unaltered. (A) Gene transcript levels in livers of individual LD
fed B6 and Ccr22/2 mice relative to B6 SD. (B) Mean values of
individual mice relative to B6 SD controls (n = 3 per group; LD
fed Ccr22/2 mice were compared to the previously described
cohort of SD and LD fed B6 mice).
(TIF)
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